PRESS RELEASE Oxitope Appoints Leading Interventional Cardiologist Gregg Stone to Advisory Board for Myocardial Reperfusion Injury Naarden, The Netherlands, 28…
Replay receives $1.5 million grant for its hypoimmunogenic technology platform Replay developing uCell™, its universal, off-the-shelf, genomically rewritten, renewable cell…